Substantivity of Oral Rinses: Comparative Study (SORCOS)

May 10, 2022 updated by: Miguel Viñas, University of Barcelona

Substantivity of Mouthrinse Formulations Containing Cetylpyridinium Chloride and O-cymen-5-Ol Compared to Placebo on Salivary Microbiota

A desirable quality of mouthrinses is substantivity an intrinsic feature of some molecules. Substantivity requires the adsorption of the agent on the oral surfaces and subsequently antimicrobial activity bacteriostatic along following hours. This work aims to quantitatively determine the substantivity of (i) a single o-Cymen-5-ol plus CPC oral rinse, (ii) a, CPC oral rinse and (iii) a o-Cymen-5-ol mouthwash on the salivary microbiota up to 4 h after their application.

Study Overview

Status

Completed

Detailed Description

One of the desirable qualities of mouthrinses is substantivity, which is defined as the persistence capacity of its antimicrobial action over time in the mouth. This is an intrinsic feature of some molecules.

Such substantivity seems to require the adsorption of the agent on the buccal surfaces and subsequently exert a certain antimicrobial activity that seems to be mostly bacteriostatic.

Substantivity is the result of multiple factors controlling or altering adhesion, life period of antimicrobial capabilities, synergisms, antagonisms, and others. In order to improve substantivity and therefore increase antimicrobial effectiveness of CPC, o-Cymen-5-ol has recently been proposed to become incorporated to oral rinses. The aim of this work is to quantitatively determine the substantivity of (i) a single o-Cymen-5-ol plus CPC oral rinse, (ii) a, CPC oral rinse and (iii) a o-Cymen-5-ol mouthwash on the salivary microbiota up to 4 h after their application.

Study Type

Interventional

Enrollment (Actual)

16

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Hospitalet de Llobregat, Barcelona, Spain, 08907
        • University of Barcelona. Campus Bellvitge

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion criteria:

  1. adult age (>18 y/o)
  2. good oral helath status
  3. minimum 24 evaluable teeth
  4. periodontal pockets ≤3 mm
  5. absence of caries & periodontal haemorrage

Exclusion Criteria:

  1. smokers
  2. prosthesis or orthodontic devices
  3. Sjögren syndrome
  4. Antibiotic treatment in the last three months
  5. Systemic disease with alteration in the production and/or composition of the saliva

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: placebo oral rinse
Placebo comparator Volume Time Active molecule 15 mL 1 min No
Participants use mouthwasher for a given time.
Non-stimulated saliva harvesting
Active Comparator: CPC oral rinse
Volume Time Active molecule 15 mL 1 min CPC containing oral rinse
Participants use mouthwasher for a given time.
Non-stimulated saliva harvesting
Active Comparator: Cymenol oral rinse
Volume Time Active molecule 15 mL 1 min Cymenol containing oral rinse
Participants use mouthwasher for a given time.
Non-stimulated saliva harvesting
Active Comparator: CPC + Cymenol oral rinse
Volume Time Active molecule 15 mL 1 min CPC+cymenol containing oral rinse
Participants use mouthwasher for a given time.
Non-stimulated saliva harvesting

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Preliminary experiments
Time Frame: one month
Measure of surviving bacteria by fluorimetry and confocal microscopy (Live & dead)
one month

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Substantivity of mouthrinse formulations containing Cetylpyridinium Chloride and O-cymen-5-Ol (single and combined) compared to Placebo on salivary microbiota
Time Frame: up to three months
Measure of surviving bacteria by fluorimetry and confocal microscopy (Live & dead) rinses plus placebo
up to three months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Miguel Viñas, PhD, University of Barcelona-Spain-

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2022

Primary Completion (Actual)

January 25, 2022

Study Completion (Actual)

February 3, 2022

Study Registration Dates

First Submitted

February 23, 2022

First Submitted That Met QC Criteria

May 3, 2022

First Posted (Actual)

May 9, 2022

Study Record Updates

Last Update Posted (Actual)

May 11, 2022

Last Update Submitted That Met QC Criteria

May 10, 2022

Last Verified

May 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 33/2021

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Prevention & Control

Clinical Trials on Oral rinse

3
Subscribe